Grace Therapeutics, Inc. Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement
Grace Therapeutics, Inc. (GRCE) had Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement of CAD 1.25 as of 2019-03-31, per its 20-F filed 2019-06-26.
Discontinued › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement · last filed 2019-06-26
- 2019-03-31: Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement 1.25 CAD.
- 2018-03-31: Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement 1.81 CAD.
- 2017-03-31: Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement 2.58 CAD.
- 2017-02-28: Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement 2.59 CAD.
| Period end | Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement |
|---|---|
| 2019-03-31 | 1.25 CAD 20-F · filed 2019-06-26 |
| 2018-03-31 | 1.81 CAD 20-F · filed 2019-06-26 |
| 2017-03-31 | 2.58 CAD 20-F · filed 2019-06-26 |
| 2017-02-28 | 2.59 CAD 20-F · filed 2019-06-26 |
| 2017-02-08 | 2.59 CAD 20-F · filed 2019-06-26 |
| 2016-02-29 | 13.52 CAD 20-F · filed 2019-06-26 |
| 2015-02-28 | 15.33 CAD 20-F · filed 2018-06-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |